MiMedx Group, Inc.

MDXGNASDAQHealthcare● Active

$3.70

$-0.04(-1.07%)

Market Cap$551099205

P/E Ratio—

52W High$7.99

52W Low$3.03

Avg Volume1.5M

Open$3.74

Beta1.46

Forecast Market Cap PE Ratio

MiMedx Group, Inc.（MDXG）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mdxg · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 15 位华尔街分析师

Buy

15 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 15 · 买入占比: 80.0%

12 个月目标价

High

$10.00

Consensus

$10.00

+170.3% upside

Low

$10.00

Median: $10 · Last Close: $3.70

MiMedx Group, Inc.（MDXG）的分析师共识为 Buy，基于过去 3 个月内 15 位华尔街分析师的评级。MDXG 的 12 个月平均目标价为 $10.00，相对当前价 $3.70 代表 +170.3% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$3.73	↑ 0.91%	$3.71	$3.76

1-day model range: $3.71–$3.76. Peak: $3.76 (+0.91%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$2	$2	$2	-35.9%
2028	$2	$2	$2	-48.5%
2029	$2	$2	$2	-54.1%
2030	$1	$2	$2	-56.9%
2031	$1	—	$2	-58.3%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

57%7%36%

8Buy

1Neutral

5Sell

RSI (14)55.7Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MDXG · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$3.68BUY

MA 10$3.66BUY

MA 20$3.63BUY

MA 50$3.64BUY

MA 100$4.28SELL

MA 200$5.62SELL

Current $MDXG · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.69BUY

EMA 10$3.67BUY

EMA 20$3.65BUY

EMA 50$3.80SELL

EMA 100$4.34SELL

EMA 200$5.16SELL

Current $MDXG · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:

Date	Brokerage	Action	Rating
2026-04-30	Citizens	Maintains	Market Outperform→Market Outperform
2026-04-20	Citizens	Maintains	Market Outperform→Market Outperform
2026-04-17	Craig-Hallum	Maintains	Buy→Buy
2026-02-17	Cantor Fitzgerald	Maintains	Overweight→Overweight
2026-01-20	Lake Street	Maintains	Buy→Buy
2025-12-17	Mizuho	Maintains	Outperform→Outperform
2025-07-31	Cantor Fitzgerald	Maintains	Overweight→Overweight
2025-07-15	Cantor Fitzgerald	Maintains	Overweight→Overweight
2025-02-27	Cantor Fitzgerald	Maintains	Overweight→Overweight
2024-08-01	Craig-Hallum	Maintains	Buy→Buy

Citizens2026-04-30

Maintains

Market Outperform→Market Outperform

Citizens2026-04-20

Maintains

Market Outperform→Market Outperform

Craig-Hallum2026-04-17

Maintains

Buy→Buy

Cantor Fitzgerald2026-02-17

Maintains

Overweight→Overweight

Lake Street2026-01-20

Maintains

Buy→Buy

Mizuho2025-12-17

Maintains

Outperform→Outperform

Cantor Fitzgerald2025-07-31

Maintains

Overweight→Overweight

Cantor Fitzgerald2025-07-15

Maintains

Overweight→Overweight

Cantor Fitzgerald2025-02-27

Maintains

Overweight→Overweight

Craig-Hallum2024-08-01

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on MiMedx Group, Inc. (MDXG) stock. Of the recent 44 rating actions, 6 were upgrades and 5 were downgrades. 15 analysts currently cover MDXG.

分析师推荐趋势

Buy ratings1 → 3↑ +2

Hold ratings0 → 0

Sell ratings0 → 0

MDXG analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$269M

↓ 21.2% YoY

Revenue Next Year

$302M

↑ 12.4% YoY

EPS This Year

$-0.06

EPS Next Year

$0.08

↓ 237.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MDXG EPS of $-0.06 for the current fiscal year, based on estimates from 3 analysts. The MDXG revenue forecast is $269M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MDXG 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MDXG 的共识目标价为 $10.00（+170.3% 上行空间），分析师共识为 Buy。

MDXG 的短期预测（明日）为 $3.73（+0.91%）。 MDXG 对 2027 年的股价预测均值为 $2。 MDXG 对 2030 年的预测区间为 $1–$2。

MiMedx Group, Inc. 在 NASDAQ 上市，代码 MDXG。MDXG 在 2027 年的整体展望偏积极，在覆盖分析师中约 80% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MDXG 预测 · 8 个问题

根据 15 位华尔街分析师，MDXG 的 12 个月平均目标价为 $10.00，最高 $10.00、最低 $10.00。若有图表，中位目标价可在上方查看。相对当前价 $3.70，隐含约 +170.3% 的上行空间。

MDXG 目标价MDXG 分析师目标价MDXG 12个月目标价目标价 MDXG

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.